Ulla Jalonen

530 total citations
13 papers, 465 citations indexed

About

Ulla Jalonen is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ulla Jalonen has authored 13 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Ulla Jalonen's work include Cytokine Signaling Pathways and Interactions (6 papers), RNA Research and Splicing (5 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Ulla Jalonen is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), RNA Research and Splicing (5 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Ulla Jalonen collaborates with scholars based in Finland, Russia and Netherlands. Ulla Jalonen's co-authors include Eeva Moilanen, Hannu Kankaanranta, Aleksi Lahti, Riina Nieminen, Katriina Vuolteenaho, Raimo K. Tuominen, Outi Sareila, Riku Korhonen, Mary B. Goldring and Tiina Leppänen and has published in prestigious journals such as Biochemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Ulla Jalonen

13 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulla Jalonen Finland 11 243 105 79 76 75 13 465
İsmail Çimen Türkiye 12 286 1.2× 103 1.0× 60 0.8× 84 1.1× 53 0.7× 14 575
Huiqiong He China 12 254 1.0× 141 1.3× 45 0.6× 92 1.2× 45 0.6× 16 519
Susumu Tsujimoto Japan 14 261 1.1× 70 0.7× 50 0.6× 73 1.0× 95 1.3× 36 502
Ann‐Marie Simeone United States 11 208 0.9× 44 0.4× 95 1.2× 96 1.3× 49 0.7× 13 399
Osamu Asano Japan 12 215 0.9× 75 0.7× 126 1.6× 35 0.5× 55 0.7× 36 652
Jacqueline Bonnet France 11 178 0.7× 65 0.6× 40 0.5× 34 0.4× 79 1.1× 13 531
L. Alexis Hoeferlin United States 14 449 1.8× 85 0.8× 45 0.6× 88 1.2× 74 1.0× 21 666
Valentina Fabbroni Italy 9 153 0.6× 122 1.2× 55 0.7× 76 1.0× 80 1.1× 12 476
Himani Sharma India 9 388 1.6× 39 0.4× 76 1.0× 77 1.0× 42 0.6× 11 577
Jane Chang United States 9 170 0.7× 75 0.7× 43 0.5× 53 0.7× 73 1.0× 12 455

Countries citing papers authored by Ulla Jalonen

Since Specialization
Citations

This map shows the geographic impact of Ulla Jalonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Jalonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Jalonen more than expected).

Fields of papers citing papers by Ulla Jalonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Jalonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Jalonen. The network helps show where Ulla Jalonen may publish in the future.

Co-authorship network of co-authors of Ulla Jalonen

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Jalonen. A scholar is included among the top collaborators of Ulla Jalonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Jalonen. Ulla Jalonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kankaanranta, Hannu, Mirkka Janka-Junttila, Pinja Ilmarinen, et al.. (2010). Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils. Journal of Inflammation. 7(1). 9–9. 41 indexed citations
2.
Leppänen, Tiina, Ulla Jalonen, Riku Korhonen, Raimo K. Tuominen, & Eeva Moilanen. (2009). Inhibition of protein kinase Cδ reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages. European Journal of Pharmacology. 628(1-3). 220–225. 10 indexed citations
3.
Jalonen, Ulla, Erja‐Leena Paukkeri, & Eeva Moilanen. (2008). Compounds That Increase or Mimic Cyclic Adenosine Monophosphate Enhance Tristetraprolin Degradation in Lipopolysaccharide-Treated Murine J774 Macrophages. Journal of Pharmacology and Experimental Therapeutics. 326(2). 514–522. 14 indexed citations
4.
Leppänen, Tiina, Ulla Jalonen, Hannu Kankaanranta, Raimo K. Tuominen, & Eeva Moilanen. (2008). Inhibition of protein kinase C βII downregulates tristetraprolin expression in activated macrophages. Inflammation Research. 57(5). 230–240. 12 indexed citations
5.
Jalonen, Ulla, Tiina Leppänen, Hannu Kankaanranta, & Eeva Moilanen. (2007). Salbutamol increases tristetraprolin expression in macrophages. Life Sciences. 81(25-26). 1651–1658. 10 indexed citations
6.
Sareila, Outi, et al.. (2006). Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS‐treated murine J774 macrophages. British Journal of Pharmacology. 147(7). 790–799. 65 indexed citations
7.
Nieminen, Riina, Aleksi Lahti, Ulla Jalonen, Hannu Kankaanranta, & Eeva Moilanen. (2006). JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages. International Immunopharmacology. 6(6). 987–996. 41 indexed citations
8.
Jalonen, Ulla, Riina Nieminen, Katriina Vuolteenaho, Hannu Kankaanranta, & Eeva Moilanen. (2006). Down‐Regulation of Tristetraprolin Expression Results in Enhanced IL‐12 and MIP‐2 Production and Reduced MIP‐3α Synthesis in Activated Macrophages. Mediators of Inflammation. 2006(1). 40691–40691. 51 indexed citations
9.
Nieminen, Riina, Aleksi Lahti, Katriina Vuolteenaho, et al.. (2005). Inhibitors of Mitogen‐Activated Protein KinasesDownregulate COX‐2 Expression in Human Chondrocytes. Mediators of Inflammation. 2005(5). 249–255. 56 indexed citations
10.
Belogurov, Georgiy A., Anssi M. Malinen, Maria V. Turkina, et al.. (2005). Membrane-Bound Pyrophosphatase of Thermotoga maritima Requires Sodium for Activity. Biochemistry. 44(6). 2088–2096. 30 indexed citations
11.
Vuolteenaho, Katriina, Teemu Moilanen, Ulla Jalonen, et al.. (2005). TGFβ inhibits IL-1 -induced iNOS expression and NO production in immortalized chondrocytes. Inflammation Research. 54(10). 420–427. 25 indexed citations
12.
Jalonen, Ulla, Aleksi Lahti, Riku Korhonen, Hannu Kankaanranta, & Eeva Moilanen. (2005). Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochemical Pharmacology. 69(5). 733–740. 34 indexed citations
13.
Lahti, Aleksi, Ulla Jalonen, Hannu Kankaanranta, & Eeva Moilanen. (2003). c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages. Molecular Pharmacology. 64(2). 308–315. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026